Gain-of-function mutations in TRPC6 have been discovered, which mediate inherited glomerular disease such as focal segmental glomerulosclerosis (FSGS) (Reiser et al., 2005; Winn et al., 2005). This evidence concerns the gene TRPC6 and focal segmental glomerulosclerosis.